Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Net Income ContractionContracting
Percentile Rank33
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-71.54M
↓ 42% vs avg
Percentile
P33
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-50.42M
Historical baseline
PeriodValueYoY Change
TTM$-71.54M+12.6%
2025$-81.89M+29.4%
2024$-116.05M+13.3%
2023$-133.82M-9.9%
2022$-121.75M-54.1%
2021$-79.00M-118.4%
2020$-36.17M-178.0%
2019$46.38M-35.5%
2018$71.96M+306.3%
2017$17.71M-